Chapter Fourteen - The Global Reach

CHAPTER FOURTEEN

The Global Reach

BAYER ISN’T JUST a German company anymore.
It’s a global infrastructure.

The company operates in over 80 countries. Its products are sold in more than 150. It has regional headquarters in North America, Latin America, Asia-Pacific, and Africa. Its supply chains stretch across continents. Its influence runs through everything from pharmacies to farmland.

There’s a good chance you’ve interacted with Bayer without even knowing it.

Maybe it was a bottle of aspirin.
Maybe it was corn sprayed with a Bayer pesticide.
Maybe it was a cancer drug manufactured under a different brand name.

In some countries, Bayer’s reach is felt through agriculture. In others, it’s pharmaceuticals. In many, it’s both. The company shapes health policy, crop regulation, and intellectual property law through lobbying, partnerships, and trade agreements.

It doesn’t always need to win the public.
It just needs to stay close to the people in charge.

Even in places where the Bayer name carries baggage, like Germany for example, the company is still seen as an employer, a taxpayer, and a national asset. Elsewhere, it’s invisible by design. Products are branded differently. Subsidiaries are siloed. The legacy is blurred.

But the structure holds.

One corporation.
Hundreds of fronts.
A network built to withstand scrutiny.

When a country sues or bans a product, the company shifts. When the law changes, the language changes. When the past resurfaces, the branding gets updated. Bayer doesn’t need to control everything directly. It just needs to be everywhere you can’t avoid.

That’s not evil.
That’s strategy.